| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |